P
LH icon

&Partners’s Labcorp LH Stock Holding History

&Partners’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97M Buy
10,611
+743
+8% +$195K 0.01% 808
2026
Q1 		$2.63M Sell
9,868
-331
-3% -$89.6K 0.01% 785
2025
Q4 		$2.56M Buy
10,199
+1,185
+13% +$315K 0.01% 744
2025
Q3 		$2.59M Buy
9,014
+125
+1% +$33.5K 0.02% 648
2025
Q2 		$2.33M Buy
8,889
+1,582
+22% +$385K 0.02% 606
2025
Q1 		$1.68M Buy
7,307
+651
+10% +$158K 0.02% 610
2024
Q4 		$1.53M Buy
6,656
+1,140
+21% +$262K 0.02% 593
2024
Q3 		$1.23M Buy
5,516
+3,166
+135% +$696K 0.02% 491
2024
Q2 		$478K Buy
+2,350
New +$478K 0.02% 558

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

&Partners's LH Position: Q2 2026 in Review

&Partners increased its Labcorp (LH) stake by 7.5% in Q2 2026, buying an estimated $195K and bringing the position to 10,611 shares worth $2.97M. The position accounts for 0.01% of the portfolio, ranked #808.

&Partners first reported a position in LH in Q2 2024 and has held it in 9 quarters since. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • &Partners held 10,611 shares of Labcorp worth $2.97M as of Q2 2026.
  • &Partners bought 743 Labcorp shares in Q2 2026, an estimated $195K.
  • Labcorp made up 0.01% of &Partners's portfolio in Q2 2026, its #808 holding.
  • &Partners first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.